bph/luts; treatments; side effects

ABSTRACT Medical management of benign prostatic hyperplasia(BPH) has progressed gradually in recent years and remains the starting point for most symptomatic patients seeking treatment. Beyond well-known alpha-blockers and 5-alpha reductase inhibitors, there is growing evidence for the use of...

Elterman gets deep! Dr. Dean Elterman, a urologist at the University of Toronto, discussed urination issues in men with prostate cancer, including BPH and overactive bladder. Valuable insights and Q&A session.